Cargando…
Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621071/ https://www.ncbi.nlm.nih.gov/pubmed/35714278 http://dx.doi.org/10.1080/21645515.2022.2085472 |
_version_ | 1784821458221924352 |
---|---|
author | Agarwal, Anurag Mathur, Surendra Bahadur |
author_facet | Agarwal, Anurag Mathur, Surendra Bahadur |
author_sort | Agarwal, Anurag |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9621071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-96210712022-11-01 Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine Agarwal, Anurag Mathur, Surendra Bahadur Hum Vaccin Immunother Licensed Vaccines – Letters Taylor & Francis 2022-06-17 /pmc/articles/PMC9621071/ /pubmed/35714278 http://dx.doi.org/10.1080/21645515.2022.2085472 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Licensed Vaccines – Letters Agarwal, Anurag Mathur, Surendra Bahadur Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine |
title | Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine |
title_full | Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine |
title_fullStr | Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine |
title_full_unstemmed | Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine |
title_short | Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine |
title_sort | letter to the editor: safety and immunogenicity of a novel recombinant rabies vaccine |
topic | Licensed Vaccines – Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621071/ https://www.ncbi.nlm.nih.gov/pubmed/35714278 http://dx.doi.org/10.1080/21645515.2022.2085472 |
work_keys_str_mv | AT agarwalanurag lettertotheeditorsafetyandimmunogenicityofanovelrecombinantrabiesvaccine AT mathursurendrabahadur lettertotheeditorsafetyandimmunogenicityofanovelrecombinantrabiesvaccine |